Integrity of SARS-CoV-2 Laboratory-Developed Tests Reply

被引：0
|
作者：
Adashi, Eli Y. [1 ]
Cohen, Glenn [2 ]
机构：
[1] Brown Univ, Dept Med Sci, 222 Richmond St, Providence, RI 02903 USA
[2] Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2022年 / 328卷 / 05期
关键词：
D O I：
10.1001/jama.2022.9467
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：478 / +
页数：3
相关论文
共 50 条
  • [1] SARS-CoV-2 Laboratory-Developed Tests Integrity Restored
    Adashi, Eli Y.
    Cohen, I. Glenn
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (13): : 1229 - 1230
  • [2] Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens
    Hogan, Catherine A.
    Garamani, Natasha
    Lee, Andrew S.
    Tung, Jack K.
    Sahoo, Malaya K.
    Huang, ChunHong
    Stevens, Bryan
    Zehnder, James
    Pinsky, Benjamin A.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)
  • [3] Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2
    Bulterys, Philip L.
    Garamani, Natasha
    Stevens, Bryan
    Sahoo, Malaya K.
    Huang, ChunHong
    Hogan, Catherine A.
    Zehnder, James
    Pinsky, Benjamin A.
    JOURNAL OF CLINICAL VIROLOGY, 2020, 129
  • [4] Comparison of commercial assays and laboratory developed tests for detection of SARS-CoV-2
    Dust, Kerry
    Hedley, Adam
    Nichol, Kim
    Stein, Derek
    Adam, Heather
    Karlowsky, James A.
    Bullard, Jared
    Van Caeseele, Paul
    Alexander, David C.
    JOURNAL OF VIROLOGICAL METHODS, 2020, 285
  • [5] Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories
    Lieberman, Joshua A.
    Pepper, Gregory
    Naccache, Samia N.
    Huang, Meei-Li
    Jerome, Keith R.
    Greninger, Alexander L.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)
  • [6] Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs)
    Kohmer, Niko
    Rabenau, Holger F.
    Hoehl, Sebastian
    Kortenbusch, Marhild
    Ciesek, Sandra
    Berger, Annemarie
    JOURNAL OF VIROLOGICAL METHODS, 2021, 291
  • [7] Comparison of saliva with oral and nasopharyngeal swabs for SARS-CoV-2 detection on various commercial and laboratory-developed assays
    Labbe, Annie-Claude
    Benoit, Patrick
    Gobeille Pare, Sarah
    Coutlee, Francois
    Levesque, Simon
    Bestman-Smith, Julie
    Dumaresq, Jeannot
    Lavallee, Christian
    Houle, Claudia
    Martin, Philippe
    Mak, Anton
    Gervais, Philippe
    Langevin, Stephanie
    Jacob-Wagner, Marieve
    Gagnon, Simon
    St-Hilaire, Manon
    Lussier, Nathalie
    Yechouron, Ariane
    Roy, David
    Roger, Michel
    Fafard, Judith
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (09) : 5333 - 5338
  • [8] Regulating Laboratory-Developed Tests
    O'Leary, Timothy J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 595 - 598
  • [9] Regulating laboratory-developed tests
    Hal Barron
    Nature Biotechnology, 2009, 27 : 419 - 419
  • [10] Regulating laboratory-developed tests
    Gibbs, Jeffrey N.
    Genetic Engineering and Biotechnology News, 2010, 30 (16):
12345